Results 331 to 340 of about 387,611 (347)
Some of the next articles are maybe not open access.
The Lancet, 2015
Dengue viruses have spread rapidly within countries and across regions in the past few decades, resulting in an increased frequency of epidemics and severe dengue disease, hyperendemicity of multiple dengue virus serotypes in many tropical countries, and autochthonous transmission in Europe and the USA.
Maria G, Guzman, Eva, Harris
+7 more sources
Dengue viruses have spread rapidly within countries and across regions in the past few decades, resulting in an increased frequency of epidemics and severe dengue disease, hyperendemicity of multiple dengue virus serotypes in many tropical countries, and autochthonous transmission in Europe and the USA.
Maria G, Guzman, Eva, Harris
+7 more sources
The Lancet, 2019
Mortality from severe dengue is low, but the economic and resource burden on health services remains substantial in endemic settings. Unfortunately, progress towards development of effective therapeutics has been slow, despite notable advances in the understanding of disease pathogenesis and considerable investment in antiviral drug discovery.
Wilder-Smith, A+3 more
openaire +3 more sources
Mortality from severe dengue is low, but the economic and resource burden on health services remains substantial in endemic settings. Unfortunately, progress towards development of effective therapeutics has been slow, despite notable advances in the understanding of disease pathogenesis and considerable investment in antiviral drug discovery.
Wilder-Smith, A+3 more
openaire +3 more sources
The Lancet, 2002
Because efforts to control dengue are flagging, this review focuses on the mechanisms underlying severe disease and on treatment options, good and bad.The year 2001 witnessed unprecedented global dengue epidemic activity in the American hemisphere, the Pacific islands and continental Asia.
openaire +3 more sources
Because efforts to control dengue are flagging, this review focuses on the mechanisms underlying severe disease and on treatment options, good and bad.The year 2001 witnessed unprecedented global dengue epidemic activity in the American hemisphere, the Pacific islands and continental Asia.
openaire +3 more sources
2006
Publisher Summary Studies have increased knowledge about dengue viruses and the diseases they cause. However, the goals of a safe, effective vaccine and vector eradication have been elusive. Control of dengue has been difficult to achieve because of some reasons.
Robert Putnak, Ching-Juh Lai
openaire +2 more sources
Publisher Summary Studies have increased knowledge about dengue viruses and the diseases they cause. However, the goals of a safe, effective vaccine and vector eradication have been elusive. Control of dengue has been difficult to achieve because of some reasons.
Robert Putnak, Ching-Juh Lai
openaire +2 more sources
Journal of Infection, 2014
Dengue is a mosquito-borne viral disease of expanding geographical range and increasing incidence. The vast majority of dengue cases are children less than 15 years of age. Dengue causes a spectrum of illness from mild fever to severe disease with plasma leakage and shock.
Verhagen, L.M., Groot, R. de
openaire +4 more sources
Dengue is a mosquito-borne viral disease of expanding geographical range and increasing incidence. The vast majority of dengue cases are children less than 15 years of age. Dengue causes a spectrum of illness from mild fever to severe disease with plasma leakage and shock.
Verhagen, L.M., Groot, R. de
openaire +4 more sources
Efficacy of a Tetravalent Dengue Vaccine in Children in Latin America.
Journal of the Pediatric Infectious Diseases Society, 2015Ef fi cacy of a tetravalent dengue vaccine in children in Latin America. Engl J 2015; 372:113 Dengue is a mosquito-borne disease caused by 1 of 4 virus serotypes from the fl avivirus genus present in tropical and subtropical regions. This study reports the
Rana F Hamdy
semanticscholar +1 more source
Dengue vaccines: implications for dengue control
Current Opinion in Infectious Diseases, 2017Purpose of review Dengue, the most common arbovirus, is an increasingly significant cause of morbidity worldwide. After decades of research, an approved tetravalent dengue vaccine is finally available. Models constructed using recently available vaccine efficacy data allow for a data-driven discussion of the potential impact of
Anna P. Durbin, Matthew L Robinson
openaire +3 more sources
Dengue Fever and Dengue Hemorrhagic Fever [PDF]
Dengue is an acute influenza-like disease caused by any of 4 genetically similar mosquito-borne arboviruses of the Flavivirus family. Dengue viruses are thus related to yellow fever virus, West Nile virus, Japanese encephalitis virus, and several other human pathogens.
openaire +2 more sources
Haematology in dengue and dengue haemorrhagic fever
Best Practice & Research Clinical Haematology, 2000Dengue fever (DF) and dengue haemorrhagic fever (DHF) are caused by the dengue virus. The major pathophysiological hallmark that distinguishes DHF from DF is plasma leakage as a result of increased vascular permeability. Following this leakage, hypovolaemic shock occurs as a consequence of a critical plasma volume loss.
Tanomsri Srichaikul+1 more
openaire +2 more sources